Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

Go back to Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
(NASDAQ: GELS) Delayed: 0.91 -0.13 (12.5%)
Previous Close $1.04    52 Week High
Open $1.03    52 Week Low
Day High $1.09    P/E N/A 
Day Low $0.89    EPS
Volume 297,395